September 1, 2013
GCA Altium acted as financial adviser to the shareholders of Ascribe on the £57.5m sale to EMIS Group plc.
Ascribe is a leading UK Health IT software supplier, providing secondary care-focused healthcare IT solutions. Over 70% of UK NHS Trusts, as well as healthcare providers in Hong Kong, Malaysia, Australia and New Zealand, currently use Ascribe solutions, which include e-prescribing, pharmacy, mental health, patient administration and A&E systems. Ascribe was listed on AIM from 2004 until January 2009, when it was taken private by ECI Partners in a £33m public to private transaction.
GCA Altium, having previously advised on the aforementioned P2P, was engaged by the controlling shareholders of Ascribe in late 2012 to lead a sale process.